SEC Form 4 · accession 0001179110-15-008010
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Antonio M Jr Md D Phil Gotto
Director
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $107.74 | May 14, 2015 | A | 8,000 | A | — | May 14, 2025 | Common Stock | 8,000 | 8,000 | D |
Explanation of responses
- F1The options vest in full on the earlier of (i) May 14, 2016 and (ii) the Issuer's next annual meeting of stockholders following May 14, 2015.